Bessemer Group
IMGO

Bessemer Group’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bessemer Group’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,339
Closed -$186K – 2205
2022
Q3 		$186K Hold
12,339
– – ﹤0.01% 908
2022
Q2 		$165K Hold
12,339
– – ﹤0.01% 916
2022
Q1 		$238K Buy
+12,339
New +$256K ﹤0.01% 789

Other funds holding IMGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Bessemer Group's IMGO Position: Q4 2022 in Review

Bessemer Group sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q4 2022, closing a stake of 12,339 shares — an estimated $186K sold.

Bessemer Group first reported a position in IMGO in Q1 2022 and held it in 3 quarters. The position peaked at $238K in Q1 2022. 106 funds tracked by Wall St. Rank hold IMGO as of Q4 2022.

  • Bessemer Group reported no remaining Imago BioSciences, Inc. Common stock position as of Q4 2022 after selling out during the quarter.
  • Bessemer Group sold 12,339 Imago BioSciences, Inc. Common stock shares in Q4 2022, an estimated $186K.
  • Bessemer Group first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 3 quarters.
  • Bessemer Group's Imago BioSciences, Inc. Common stock position peaked at $238K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q4 2022.

Based on Bessemer Group's 13F filing for Q4 2022, filed 13 Feb 2023.